These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31702027)

  • 1. MicroRNA‑125a‑5p controls the proliferation, apoptosis, migration and PTEN/MEK1/2/ERK1/2 signaling pathway in MCF‑7 breast cancer cells.
    Liang Z; Pan Q; Zhang Z; Huang C; Yan Z; Zhang Y; Li J
    Mol Med Rep; 2019 Nov; 20(5):4507-4514. PubMed ID: 31702027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR‑125a‑5p reverses epithelial‑mesenchymal transition and restores drug sensitivity by negatively regulating TAFAZZIN signaling in breast cancer.
    Li D; Chen L; Zhang X; Wang Y; Huang C; Li J; He F; He W
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34549308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RASSF7 promotes cell proliferation through activating MEK1/2-ERK1/2 signaling pathway in hepatocellular carcinoma.
    Zhang M; Li Q; Zhang L; Wang Y; Wang L; Li Q; He T; Wan B; Wang X
    Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):73-79. PubMed ID: 29729697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of metastasis-associated in colon cancer 1 inhibition by small hairpin RNA on ovarian carcinoma OVCAR-3 cells.
    Zhang R; Shi H; Chen Z; Wu Q; Ren F; Huang H
    J Exp Clin Cancer Res; 2011 Sep; 30(1):83. PubMed ID: 21923915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PtdIns(3,4,5)P3-dependent Rac Exchanger 1 (PREX1) Rac-Guanine Nucleotide Exchange Factor (GEF) Activity Promotes Breast Cancer Cell Proliferation and Tumor Growth via Activation of Extracellular Signal-regulated Kinase 1/2 (ERK1/2) Signaling.
    Liu HJ; Ooms LM; Srijakotre N; Man J; Vieusseux J; Waters JE; Feng Y; Bailey CG; Rasko JE; Price JT; Mitchell CA
    J Biol Chem; 2016 Aug; 291(33):17258-70. PubMed ID: 27358402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-21 inhibitor suppresses cell proliferation and colony formation through regulating the PTEN/AKT pathway and improves paclitaxel sensitivity in cervical cancer cells.
    Du G; Cao D; Meng L
    Mol Med Rep; 2017 May; 15(5):2713-2719. PubMed ID: 28447761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
    Menendez JA; Vellon L; Colomer R; Lupu R
    Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic interplay of two molecular switches enabled by the MEK1/2-ERK1/2 and IL-6-STAT3 signaling axes controls epithelial cell migration in response to growth factors.
    Qin L; Cao X; Kaneko T; Voss C; Liu X; Wang G; Li SS
    J Biol Chem; 2021 Oct; 297(4):101161. PubMed ID: 34480897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-securinine inhibits cell growth and metastasis of human androgen-independent prostate cancer DU145 cells via regulating mitochondrial and AGTR1/MEK/ERK/STAT3/PAX2 apoptotic pathways.
    Zhang D; Liu H; Yang B; Hu J; Cheng Y
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30975734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR‑101 regulates the cell proliferation and apoptosis in diffuse large B‑cell lymphoma by targeting MEK1 via regulation of the ERK/MAPK signaling pathway.
    Huang Y; Zou Y; Lin L; Ma X; Zheng R
    Oncol Rep; 2019 Jan; 41(1):377-386. PubMed ID: 30365139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNAi-mediated MEK1 knock-down prevents ERK1/2 activation and abolishes human hepatocarcinoma growth in vitro and in vivo.
    Gailhouste L; Ezan F; Bessard A; Frémin C; Rageul J; Langouët S; Baffet G
    Int J Cancer; 2010 Mar; 126(6):1367-77. PubMed ID: 19816936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA‑142‑5p modulates breast cancer cell proliferation and apoptosis by targeting phosphatase and tensin homolog.
    Xu W; Wang W
    Mol Med Rep; 2018 Jun; 17(6):7529-7536. PubMed ID: 29620260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. lncRNA CYTOR promotes tamoxifen resistance in breast cancer cells via sponging miR‑125a‑5p.
    Liu Y; Li M; Yu H; Piao H
    Int J Mol Med; 2020 Feb; 45(2):497-509. PubMed ID: 31894257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27
    Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH
    Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of miR‑125a‑5p as a tumor suppressor of renal cell carcinoma, regulating cellular proliferation, migration and apoptosis.
    Chen D; Li Y; Su Z; Yu Z; Yu W; Li Y; Gui Y; Yang S; Lai Y
    Mol Med Rep; 2015 Feb; 11(2):1278-83. PubMed ID: 25370896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.
    Marzec M; Kasprzycka M; Liu X; Raghunath PN; Wlodarski P; Wasik MA
    Oncogene; 2007 Feb; 26(6):813-21. PubMed ID: 16909118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1.
    Bhowmik T; Gomes A
    Chem Biol Interact; 2017 Apr; 268():119-128. PubMed ID: 28322778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-223 Regulates Cardiac Fibrosis After Myocardial Infarction by Targeting RASA1.
    Liu X; Xu Y; Deng Y; Li H
    Cell Physiol Biochem; 2018; 46(4):1439-1454. PubMed ID: 29689569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase Cdelta supports survival of MDA-MB-231 breast cancer cells by suppressing the ERK1/2 pathway.
    Lønne GK; Masoumi KC; Lennartsson J; Larsson C
    J Biol Chem; 2009 Nov; 284(48):33456-65. PubMed ID: 19833733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CT45A1 siRNA silencing suppresses the proliferation, metastasis and invasion of lung cancer cells by downregulating the ERK/CREB signaling pathway.
    Tang F; Tang S; Guo X; Yang C; Jia K
    Mol Med Rep; 2017 Nov; 16(5):6708-6714. PubMed ID: 28901509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.